News

FDA head falsely claims no scientists laid off, as agency shutters food safety labs
The head of the Food and Drug Administration has repeatedly claimed in recent interviews that no scientists have been laid ...
FDA chief says they're looking at whether to approve COVID shots for next winter
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
American Diversified Holdings Corporation (ADHC) Receives Favorable FDA Review
Dr. Stephen C. Weber, MD, FACS Head of ADHC's Medical Advisory Board To Lead Next Stage Of GlucoGuard Development Del Mar, ...
BioSpace1d
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.
MyJoyOnline1d
We’ll not sacrifice public safety for money – FDA
The Upper East Regional Office of the Food and Drugs Authority (FDA) has cautioned sachet water producers against production ...
BioSpace1d
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...
Fierce Biotech1d
Spruce halves head count, narrowing focus to get ex-BioMarin drug to FDA
Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...
US to Phase Out Many Synthetic Food Dyes, Kennedy and FDA Head Say
U.S. Food and Drug Administration (FDA) Commissioner Marty Makary announces the FDA’s intent to phase out the use of ...
Fierce Pharma4d
Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in head and neck cancer subtype
Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...
Avoid these foods right now — the 10 ‘really risky’ items causing illness, according to Consumer Reports
CR specifically examined the number of foodborne illnesses and deaths in 2024, the spread of the outbreaks and food recalls.
Fierce Pharma12d
Former CBER director warns FDA staff cuts could upend drug review timelines as early as next year: BMO
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...